Cardinal Health, Inc. (CAH) Presents at Baird Global Healthcare Transcript

Eric Coldwell
Senior Research Analyst

Good to go. Great. Good morning, everyone. My name is Eric Coldwell. I cover pharma services, health care distribution and related industries for Baird. And it’s a great pleasure to have Cardinal Health with us here today. On stage with me, Jason Hollar, CEO; Aaron Alt, CFO; and of course, Matt Sims, who leads up Investor Relations. And we’re very excited to have Cardinal. This has been a lot of fun for the last few years since you joined. And officially, I had a few best picks for the year, but officially, Cardinal was my top idea for 2025 and…

Matt Sims
Vice President of Investor Relations

Well, we enjoy making you look good.

Eric Coldwell
Senior Research Analyst

Thank you for making me look good. I needed some help for sure. I’m going to let Matt take a couple of minutes into disclosures, and we’ll just jump right in.

Matt Sims
Vice President of Investor Relations

Perfect. Well, thanks for hosting us, Eric. It’s great to be here as always. And before we begin, just a few reminders. So we will be making forward-looking statements today, which are subject to risks and uncertainties that could cause our actual results to differ materially from those projected or implied. For a description of these factors, please review our SEC filings, which can be found on our IR website at ir.cardinalhealth.com. Back to you.